Medical News

RSS

Blocking pathway for generating energy can kill cancer cells

Cancer Research UK scientists have found that blocking the pathway used by some kidney cancer cells to generate energy can kill the cancer cells, sparing the healthy ones.

18 Aug 2011

How the Medco-Express Scripts merger could impact consumer pocketbooks

You probably haven't heard of either Express Scripts or Medco Health Services, but their plans to merge in a $29 billion deal, announced last month, may have an impact on your pocketbook.

18 Aug 2011

Pressure-reduction mattresses could help hospitals reduce health care costs

Hospitals could reduce health care costs arising from pressure ulcers, commonly known as bedsores, by investing in pressure-reduction mattresses for elderly patients in emergency departments, according to new research from the University of Toronto.

18 Aug 2011

CCP expands hybrid model services to large medical groups and health systems

Concierge Choice Physicians (CCP), the nation's pioneer in the hybrid model of concierge medicine programs, announced today the expansion of its services to mid-size and large medical groups, and to national and regional health systems.

18 Aug 2011

EMA accepts Merck and ARIAD's MAA for ridaforolimus to treat metastatic bone sarcomas

Merck, known outside the United States and Canada as MSD, and ARIAD Pharmaceuticals, Inc., today announced that the European Medicines Agency (EMA) has completed its administrative validation process for the regulatory application for ridaforolimus, an investigational oral mTOR inhibitor developed for the treatment of metastatic soft-tissue or bone sarcomas in patients who had a favorable response to chemotherapy.

18 Aug 2011

MSF warns global shortage of drug-resistant TB treatment likely

As countries increase the use of the GeneXpert test, a two-hour molecular TB test released in 2010, "enabl[ing] them to diagnose more patients with drug-resistant tuberculosis (DR-TB), a worldwide shortage of the drugs to treat these patients is likely, Medecins Sans Frontieres (MSF) warns," according to PlusNews.

18 Aug 2011

National analysis identifies Columbus as one of the Hypertension Hot Spots in the U.S.

A national analysis conducted by Sperling's BestPlaces and sponsored by Takeda Pharmaceuticals North America, Inc., identified Columbus, Ohio, as one of the nation's Hypertension Hot Spots, or cities that have hypertension risk factors and complications.

18 Aug 2011

Henry Schein authorizes repurchase of $200M shares of common stock

Henry Schein, Inc., the largest provider of health care products and services to office-based practitioners, today announced that its Board of Directors has authorized the repurchase of up to $200 million of shares of the Company's common stock.

18 Aug 2011

BTI completes SUGARDOWN human clinical study on blood sugar management

Boston Therapeutics, Inc. (BTI), a public company registered with the SEC and a developer of diabetes therapeutics, announced today the completion of a trial in healthy volunteers performed at the University of Sydney on SUGARDOWN, a dietary supplement designed to reduce post-meal elevation of blood glucose.

18 Aug 2011

Kensey Nash fourth quarter total revenues decrease 14% to $18.7 million

Kensey Nash Corporation, a medical device company primarily focused on regenerative medicine for a wide range of medical procedures, today reported the results for its fourth quarter and fiscal year ended June 30, 2011.

18 Aug 2011

SuccessEHS to offer updated software licensing option

SuccessEHS announced today that it will offer an updated licensing option designed in conjunction with its Success Architecture. SuccessEHS's "Success Architecture" minimizes risk with an industry-leading technical framework and helps lay the foundation for clients' success.

18 Aug 2011

Celgene expands share repurchase program

Celgene Corporation announced the Company's Board of Directors has authorized the repurchase of up to an additional $2 billion of the Company's common stock.

18 Aug 2011

IU scientist to investigate salubrinal drug against osteoporosis

An Indiana University scientist studying human bone growth has received a $2.6 million grant from the U.S. Department of Defense to study a chemical compound with potential to fight osteoporosis and accelerate broken bone healing.

18 Aug 2011

New leukemia drug in early clinical testing offers some clues for better treatment

While testing a new drug designed to treat chronic leukemia, researchers at Cleveland Clinic discovered new markers that could identify which patients would receive maximum benefit from the treatment.

18 Aug 2011

SAMHSA-funded project to develop a Prescriber's Clinical Support System

Medical professionals will gain access to free clinical support in the use of opioid medications through a new grant announced by SAMHSA today. SAMHSA awarded $1.5 million to the American Academy of Addiction Psychiatry to develop a Prescriber's Clinical Support System.

18 Aug 2011

Insight into how HIV reservoirs may form

Much like cities organize contingency plans and supplies for emergencies, chronic infectious diseases like HIV form reservoirs that ensure their survival in adverse conditions. But these reservoirs-small populations of viruses or bacteria of a specific type that persist despite attack by the immune system or drug treatment-are not always well understood.

18 Aug 2011

Online brain training reduces depression, improves cognitive functions

CogniFit brain fitness program can improve cognitive functions of everyday living in individuals with depression.

18 Aug 2011

Winner Medical receives CCI's COTTON USA Mark license

Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton products in China, proudly announced today that it was granted the COTTON USA Mark license by Cotton Council International ("CCI") for its PurCotton products, which use and contain 100% U.S.-grown cotton.

18 Aug 2011

International symposium on Persistent Organic Pollutants to take place in Brussels

The 31st international symposium on Persistent Organic Pollutants (Dioxin 2011) will take place in Brussels from August 22 to 25, 2011, bringing together close to 1000 specialists from the world over.

18 Aug 2011

U.S. research collaboration addresses threat of cancer in Latin America

In a post in the State Department's "DipNote" blog, Krysten Carrera, a Presidential Management fellow at the National Cancer Institute currently serving in the Bureau of International Organization Affairs, discusses "the growing international effort to address the threat of chronic non-communicable diseases."

18 Aug 2011